Literature DB >> 15054578

[Acute severe asthma in older adults].

G Schultze-Werninghaus1, H W Duchna, K Rasche, M Orth.   

Abstract

The underlying causes of acute severe or life threatening asthma are infections with respiratory viruses or Mycoplasma pneumoniae, rather than bacterial infections. In addition, exposure to various agents such as allergens, non-specific irritants or drugs, and inadequate long-term treatment may be responsible. High flow oxygen therapy, high dose topic beta(2)-agonists and systemic glucocorticosteroids should be used as baseline therapy in outpatients. In hospital, intravenous therapy-eventually including sedatives-can be administered under controlled or intensive care conditions. In patients with increasing respiratory pump weakness and alveolar hypoventilation, non-invasive and/or invasive mechanical ventilation may be required. In ventilated asthma patients permissive hypercarbia has been shown to reduce complications such as pneumothorax. Bronchoscopy and bronchial lavage are recommended for patients ventilated with increasing pressures or when atelectasis occurs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15054578     DOI: 10.1007/s00108-004-1174-y

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  14 in total

1.  Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics.

Authors:  S E Wenzel; L B Schwartz; E L Langmack; J L Halliday; J B Trudeau; R L Gibbs; H W Chu
Journal:  Am J Respir Crit Care Med       Date:  1999-09       Impact factor: 21.405

2.  British guideline on the management of asthma.

Authors: 
Journal:  Thorax       Date:  2003-02       Impact factor: 9.139

3.  [Asthma therapy in children and adults. Recommendations of the German Respiratory League of the German Society of Pneumology].

Authors:  R Wettengel; D Berdel; D Hofmann; J Krause; C Kroegel; R F Kroidl; W Leupold; H Lindemann; H Magnussen; R Meister; H Morr; D Nolte; K F Rabe; D Reinhardt; R Sauer; G Schultze-Werninghaus; D Ukena; H Worth
Journal:  Med Klin (Munich)       Date:  1998-11-15

Review 4.  Use of helium-oxygen mixtures in the treatment of acute asthma: a systematic review.

Authors:  Gustavo J Rodrigo; Carlos Rodrigo; Charles V Pollack; Brian Rowe
Journal:  Chest       Date:  2003-03       Impact factor: 9.410

Review 5.  Heliox vs air-oxygen mixtures for the treatment of patients with acute asthma: a systematic overview.

Authors:  Anthony M-H Ho; Anna Lee; Manoj K Karmakar; Peter W Dion; David C Chung; LeeAnne H Contardi
Journal:  Chest       Date:  2003-03       Impact factor: 9.410

Review 6.  Permissive hypercapnic ventilation.

Authors:  D V Tuxen
Journal:  Am J Respir Crit Care Med       Date:  1994-09       Impact factor: 21.405

7.  The effectiveness of IV beta-agonists in treating patients with acute asthma in the emergency department: a meta-analysis.

Authors:  Andrew H Travers; Brian H Rowe; Samantha Barker; Arthur Jones; Carlos A Camargo
Journal:  Chest       Date:  2002-10       Impact factor: 9.410

8.  The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. European Network for Understanding Mechanisms of Severe Asthma.

Authors: 
Journal:  Eur Respir J       Date:  2003-09       Impact factor: 16.671

Review 9.  The assessment and management of adults with status asthmaticus.

Authors:  T C Corbridge; J B Hall
Journal:  Am J Respir Crit Care Med       Date:  1995-05       Impact factor: 21.405

Review 10.  Acute severe asthma.

Authors:  E R McFadden
Journal:  Am J Respir Crit Care Med       Date:  2003-10-01       Impact factor: 21.405

View more
  1 in total

Review 1.  [Bronchial asthma and chronic obstructive pulmonary disease with acute exacerbation: preclinical differential diagnostic and emergency treatment].

Authors:  B Friege; L Friege; J Pelz; M Weber; T von Spiegel; S Schröder
Journal:  Anaesthesist       Date:  2009-06       Impact factor: 1.041

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.